START FREE TRIAL

Ishan Majumdar

This Telehealth Stock Rally By RFK Jr. Looks Like Policy; It’s Actually A Margin SHIFT

Hims & Hers Health (NYSE:HIMS) did not report a surprise quarter, launch a blockbuster product, or raise guidance when...

Did Meta & Snap Just Hit An Attention LIMIT That Changes Ad Economics?

Meta Platforms (NASDAQ:META) and Snap Inc. (NYSE:SNAP) are often discussed as ad platforms, AI stories, or restructuring cases. That...

Amazon vs Starlink Is The Story; But The REAL SHIFT Is Elsewhere!

Amazon (NASDAQ:AMZN) has never been shy about spending big when it sees a control point forming.The $10.8 billion Globalstar...

The $100 Billion LIE That Moved The Markets!

A false report about Nvidia (NASDAQ:NVDA), Dell Technologies (NYSE:DELL), and HP Inc. (NYSE:HPQ) did more than spark a fast...

The Market Is Pricing Trump’s Bluff But Physical Flows Tell A DIFFERENT STORY!

The new policy shock is unusually clear, even if the market’s interpretation is not. After talks between the U.S....

The Meta + CoreWeave Deal Looks Good; But Something DOESN’T ADD UP!

CoreWeave (NASDAQ: CRWV) and Meta Platforms (NASDAQ: META) just gave the market a flashy headline: a $21 billion AI...
spot_imgspot_img

Eli Lilly’s Foundayo & The GLP-1 Pivot From Innovation to Access Control!

Most coverage of Eli Lilly’s(NYSE:LLY) Foundayo launch has treated it like the next round in the company’s fight with...

Meta’s AI Launch Looks Like Progress — But Something Feels Off

Meta Platforms (NASDAQ:META) just gave investors a fresh AI headline, but the more interesting story sits under the surface....

Is Globalstar A Shortcut For Amazon—But A REAL Constraint For Apple?

When a stock jumps on takeover chatter, the easy explanation is speculation. That is only part of the story here....

Apple & The AI Supply Crunch — What Wall Street Is Missing!

Apple (NASDAQ:AAPL) is not the company most people think of when the market starts talking about AI bottlenecks. That...

Nike’s China Slump Is Starting to Look Like Something More!

Nike (NYSE:NKE) has spent years selling the idea that great brands travel well. In China, that assumption is starting...

This “Broken” Biotech Just Forced Wall Street To Blink

Apellis Pharmaceuticals (NASDAQ:APLS) did not suddenly discover a miracle on Tuesday. What changed was the price investors were willing...